References
- Tormey D C, Davis T E, Waalkes TP. Tumor markers. Principles of cancer treatment, SK Carter, E Glatstein, RB Livingston. McGraw-Hill. 1982; 170–177
- Blomquist CP. Cancer and bone. Serum calcium levels in patients with cancer. Thesis, Faculty of Medicine, University of Helsinki, Finland 1988
- Kessel D, Sykes E, Henderson M. Glycosylaansferase levels in tumors metastatic to liver and in uninvolved liver tissue. J Natl Cancer Inst 1977; 59: 29–33
- Minton J P, Chevinsky A. Present status of tumor markers. Semh Surg Oncol 1989; 5: 426–435
- Lamen R. Clinical significance of tumor markers. Wien Klin Wochenschr. 1989; 101: 464–472
- Moore M, Jones D J, Schofield PF, Hamden DG. Current status of tumor markers in large bowel cancer. World J Surg 1989; 13: 52–59
- Wilson J NG, Jungner F. Principles and practise of screening for disease. Public Health Papers N. 34. WHO, Geneve 1968
- Chu T M, Murphy GP. Carciniembryonic antigen: Evaluation as screening assay in noncancer clinics. NY State J Med 1978; 78: 879–884
- Britton KE. Nuclear medicine. Radiology in the management of cancer, RJ Johnson, B Eddleslon, RD Hunter. Churchill Livingstone, London 1990; 1–24
- Ruddon RW. Immunologic and biochemical markers in the diagnosis and management of poorly differentiated neoplasms and cancres of unknown primary. Poorly differentiated neoplasms and tumors of unknown origin, MF Fer, FA Greco, RK Oldham. Grune & Stratton. Inc. 1986; 75–100
- Chigira M, Shinozaki T. Diagnostic value of serum markers in skeletal metastasis of carcinomas. Arch Orthop Trauma Surg 1990; 109: 247–251
- Klepp O, Flodgren P, Maamnan-Moe H, et al. Early clinical stages (CS 1. CS 1Mk+, CS2A) of non-seminomatous testis cancer. Ann Oncol 1990; 1: 281–88
- Ross DS. Long-term management of differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19: 719–739
- McKnight A, Mannell A, Shperling I. The role of carbohydrate antigen Ca19–9 as a tumour marker of oesophageal cancer. Br J cancer 1989; 60: 249–251
- Garcia M B, Blankenstein M A, van der Wall E, Nortier J WR, Schornagel J H, Thijssen J HH. Comparison of breast cancer mucin (BCM) and Ca15–3 in human breast cancer. Breast Cancer Res Treat 1990; 17: 69–76
- Ruther U, Luthgens M, Bauerle K, et al. Surveillance and M-VEC therapy monitoring of patients with advanced carcinoma of the urinary tract by TPA. J Tumor Marker Oncol 1989; 4: 303–321
- Gargano G, Correale M, Abbate I, et al. The role of tumour markers in ovarian cancer. Clin Exp Obstet Gynecoll 1990; 7: 23–29
- Hareyama M, Imai K, Kubo K, et al. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer 1991; 67: 2269–2274